Specialty Committee


The Speciality Committee was created in the early nineties by the EAACI Ex.Com to join the 3 Allergology European structures:

 

IMG 4668

 
Chair of Specialty Committee (right)
Roy Gerth van Wijk
The Netherlands

Secretary of Specialty Committee (left)
Norbert Mülleneisen
Germany

- EAACI, the European Academy of Allergology and Clinical Immunology
- UEMS Section

The Speciality Committee aims to link these three structures to organize a fruitful promotion of the speciality throughout Europe.

The Specialty Committee interacts closely with the relevant Section of the UEMS (the European Union of Medical Specialists) and investigates aspects of Allergology as a Medical Specialty.


Specialty Committee position papers

"The roadmap for allergology in Europe: The subspecialty of allergology as "stop-over" on the way to a full specialty. An EAACI position statement" here.
"The roadmap for Allergology specialty and allergy care in Europe and adjacent countires. An EAACI position paper" here.

Last updated 13 September 2019
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel